Nouvelles de la Bourse
Dernières actualités financières · Mis à jour Jul 24, 2026
À quoi savoir sur cette investissement plus important de ce fonds sur Lionsgate Studios face à une augmentation de 85% de son action
What to Know About This Fund’s Bigger Bet on Lionsgate Studios Amid an 85% Stock Surge
The panel is divided on Lionsgate's future, with some seeing it as a potential takeover target due to its content …
Pourquoi cette action 'ennuyeuse' est un achat fort à acheter maintenant
Why This "Boring" Stock Is a Strong Buy Right Now
The panel's net takeaway is that Coca-Cola's current valuation (24x forward P/E) leaves little room for margin compression, and its …
Pourquoi l'action Charles Schwab a augmenté vendredi
Why Charles Schwab Stock Bumped Higher on Friday
Panelists are neutral on Schwab, citing rate sensitivity and structural risks, while acknowledging potential ROE improvement from deposit normalization.
Cette action technologique a généré de l'argent pour des investisseurs patients pendant 5 ans, et elle reste encore pas chère
This Tech Stock Has Printed Money for Patient Investors for 5 Years, and It's Still Cheap
Onto Innovation's growth prospects hinge on the successful ramp of the Dragonfly G5 platform and maintaining its large HBM backlog. …
Cette action de voyage a chuté de 38 %, mais un fonds vient d'augmenter sa position de 24 millions de dollars
This Travel Stock Is Down 38%, but a Fund Just Increased Its Position by $24 Million
The panel generally expresses skepticism about TRIP's turnaround prospects, with concerns about the core hotel business's decay, lack of operating …
'Ils m'ont retiré 20 000 £ que je ne devais pas' : Des parents touchés par des erreurs de pension alimentaire
'They took £20,000 I didn't owe': Parents hit by child maintenance errors
The panel agrees that the Child Maintenance Service's (CMS) high appeal overturn rate and lack of transparency regarding the monetary …
Prédiction : Cette action pourrait doubler d'ici 2031
Prediction: This Stock Could Double By 2031
Panelists agreed that Exelixis' valuation hinges on the success of zanzalintinib, with significant risks around its late-stage trials and patent …
Les avocats d'Elon Musk et d'OpenAI présentent leur plaidoirie finale dans un procès qui pourrait façonner l'avenir de l'IA
Lawyers for Elon Musk and OpenAI make their final case in a trial that could shape AI's future
The panel consensus is that the trial's outcome, while important, may not be the most significant risk factor for OpenAI's …
Bicara Stock Est En Hausse de 50%, et un Investisseur en Biotechnologie en a Fait un Pari de Portefeuille de 29%
Bicara Stock Is Up 50%, and One Biotech Investor Has Made It a 29% Portfolio Bet
Omega Fund's 29% allocation to Bicara (BCAX) reflects high conviction in ficerafusp alfa's Phase 2/3 trial, but the extreme concentration …
Pourquoi un fonds a ouvert une position de 9 millions de dollars dans Ziff Davis malgré une vente majeure de l'entreprise
Why One Fund Opened a $9 Million Position in Ziff Davis Amid a Major Business Sale
The panel generally agrees that Ziff Davis' strategy to divest its Connectivity segment is a necessary move, but the success …
Les démocrates dénoncent Trump pour un « fonds de caisse » dans un possible règlement de poursuite de l'IRS
Democrats blast Trump over 'slush fund' in possible IRS lawsuit settlement
The panel is divided on the proposed $1.7 billion settlement, with concerns raised about potential governance issues and market uncertainty, …
Trump a fait de gros investissements dans les actions technologiques au premier trimestre 2026, révèlent de nouveaux documents
Trump went big on tech stocks in first quarter of 2026, new filings show
The panel is divided on the implications of President Trump's 3,700+ transactions in Q1 2026, with concerns raised about potential …